Xavier Becerra, President Joe Biden’s outgoing Health and Human Services secretary, is lamenting Americans’ abysmal distrust in federal health agencies while

Biden’s secretary of health and human services defended him on Tuesday amid an open revolt within the Democratic Party over his ability to proceed as their nominee this fall.

BECERRA’S FINAL ACT — During the unveiling of his official portrait on Tuesday, HHS Secretary Xavier Becerra, who will soon depart the agency, highlighted the record number of people who have signed up for health insurance since he took the helm of the sprawling agency — and President Joe Biden’s role in it, Chelsea reports.

The Biden administration said a record 24.2 million Americans enrolled in individual coverage under the Affordable Care Act also known as Obamacare.

Becerra’s unwavering support for the Affordable Care Act helped land him the top job at the DHS, running a $1.7 trillion agency, developing vaccines and inspecting foods on supermarket shelves.

As President Biden's term ends, his administration's focus on diversity is highlighted by historic appointments, including the first Native American Cabinet official and the first female Treasury Secretary.

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new pandemic grow.

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new pandemic grow.

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers.

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden administration announced Friday.